Evidence map›Paper›PMID 24933286›Full record

ArticleAlcohol (Fayetteville, N.Y.)2014

Ethosuximide reduces electrographical and behavioral correlates of alcohol withdrawal seizure in DBA/2J mice.

Melissa A Riegle, Melissa L Masicampo, Erin H Caulder, Dwayne W Godwin

Open access · greenAbstract read
In one paragraph

Article in Alcohol (Fayetteville, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Melissa A RiegleNeuroscience Program, Wake Forest University School of Medicine, Winston-Salem, NC, USA; Department of Neurobiology and Anatomy, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Melissa L MasicampoDepartment of Neurobiology and Anatomy, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Erin H CaulderDepartment of Neurobiology and Anatomy, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Dwayne W GodwinNeuroscience Program, Wake Forest University School of Medicine, Winston-Salem, NC, USA; Department of Neurobiology and Anatomy, Wake Forest University School of Medicine, Winston-Salem, NC, USA. Electronic address: dgodwin@wakehealth.edu.
Wake Forest University · US

Funding

MULTI-DISCIPLINARY TRAINING IN THE BIOLOGY OF ALCOHOLISMT32AA007565 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BRIAN A MCCOOL · 1994 to 2026
$10.1M
Mechanisms of Alcohol WithdrawalR01AA016852 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI GODWIN, DWAYNE W · 2008 to 2024
$5.5M
T-Channel Dysregulation during Alcohol Withdrawal: Mechanisms and Novel TherapiesF31AA021322 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SMALDINO, MELISSA ANN · 2012 to 2013
$79k
NIAAA NIH HHS F31 AA021322NIAAA NIH HHS F31AA021322NIAAA NIH HHS R01 AA016852NIAAA NIH HHS R01AA016852NIAAA NIH HHS T32 AA007565NIAAA NIH HHS T32AA07565
6 · The paper itself

Abstract

Chronic alcohol abuse depresses the nervous system and, upon cessation, rebound hyperexcitability can result in withdrawal seizure. Withdrawal symptoms, including seizures, may drive individuals to relapse, thus representing a significant barrier to recovery. Our lab previously identified an upregulation of the thalamic T-type calcium (T channel) isoform CaV3.2 as a potential contributor to the generation and propagation of seizures in a model of withdrawal. In the present study, we examined whether ethosuximide (ETX), a T-channel antagonist, could decrease the severity of ethanol withdrawal seizures by evaluating electrographical and behavioral correlates of seizure activity. DBA/2J mice were exposed to an intermittent ethanol exposure paradigm. Mice were treated with saline or ETX in each withdrawal period, and cortical EEG activity was recorded to determine seizure severity. We observed a progression in seizure activity with each successive withdrawal period. Treatment with ETX reduced ethanol withdrawal-induced spike and wave discharges (SWDs), in terms of absolute number, duration of events, and contribution to EEG power in the 6-10 Hz frequency range. We also evaluated the effects of ETX on handling-induced convulsions. Overall, we observed a decrease in handling-induced convulsion severity in mice treated with ETX. Our findings suggest that ETX may be a useful pharmacological agent for studies of alcohol withdrawal and treatment of resulting seizures.

Indexed as

Alcohol Withdrawal SeizuresAnimalsCalcium Channel BlockersCalcium Channels, T-TypeElectroencephalographyEthanolEthosuximideHandling, PsychologicalMaleMice, Inbred DBARandom AllocationCalcium Channel BlockersCalcium Channels, T-TypeEthanolEthosuximideAlcoholEthosuximideSeizureT-type calcium channelWithdrawal

Identifiers

PMID24933286
PMCPMC4378959
OpenAlexW1985360441

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.